Effectiveness of IGlarLixi, a Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide, in People with Type 2 Diabetes
Crossref DOI link: https://doi.org/10.1007/s13300-021-01128-5
Published Online: 2021-08-06
Published Print: 2021-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kis, János Tibor
Nagy, Gábor
Kovacs, Gábor
Text and Data Mining valid from 2021-08-06
Version of Record valid from 2021-08-06
Article History
Received: 22 June 2021
Accepted: 21 July 2021
First Online: 6 August 2021